DaVita, a steadfast leader in kidney care research and innovation, is unveiling six new studies at the American Society of ...

"We are excited to welcome KCC to INNOCURA," said Dr. Robert Provenzano, Chief Executive Officer of INNOCURA Nephrology. "For decades, KCC's nephrologists have provided exceptional care to patients ...

Detailed price information for Davita Healthcare Partners Inc (DVA-N) from The Globe and Mail including charting and trades.

DaVita missed Wall Street estimates for third-quarter profit on Wednesday, as the kidney dialysis provider grappled with rising patient care costs and declining treatment volumes.

Dialysis provider DaVita Inc. (NYSE:DVA) met Wall Streets revenue expectations in Q3 CY2025, with sales up 4.8% year on year ...

DVA's Q3 earnings miss estimates despite revenue growth, as margins tightened and shares slipped post-results.

Despite the earnings miss, DaVita reaffirmed its full-year adjusted earnings guidance of $10.35 to $11.15 per share, which aligns with the analyst consensus of $10.80.

Establishing a Foundation for Home Therapy Innovation and Adoption Despite the clinical and quality-of-life benefits of home dialysis, the modality remains significantly underutilized, with only ...

Last week, the Athens Police Department had the opportunity to demonstrate local law enforcement’s commitment to community ...

The "Saudi Arabia Dialysis Market Report by Type, Product & Services, End User, States and Company Analysis, 2025-2033" report has been added to ResearchAndMarkets.com's offering. Saudi Arabia ...

Davita Healthcare ( ($DVA) ) has released its Q3 earnings. Here is a breakdown of the information Davita Healthcare presented to its investors.

Companies are warning of a handful of consequential immigration enforcement risks beyond workforce shortages, showing how the ...